APA

Brandon E. F. A., Bosch T. M., Deenen M. J., Levink R., van der Wal E., van Meerveld J. B. M., Bijl M., Beijnen J. H., Schellens J. H. M. & Meijerman I. (20060404). Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines. : Toxicology and applied pharmacology.

Chicago

Brandon Esther F A, Bosch Tessa M, Deenen Maarten J, Levink Rianne, van der Wal Everdina, van Meerveld Joyce B M, Bijl Monique, Beijnen Jos H, Schellens Jan H M and Meijerman Irma. 20060404. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines. : Toxicology and applied pharmacology.

Harvard

Brandon E. F. A., Bosch T. M., Deenen M. J., Levink R., van der Wal E., van Meerveld J. B. M., Bijl M., Beijnen J. H., Schellens J. H. M. and Meijerman I. (20060404). Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines. : Toxicology and applied pharmacology.

MLA

Brandon Esther F A, Bosch Tessa M, Deenen Maarten J, Levink Rianne, van der Wal Everdina, van Meerveld Joyce B M, Bijl Monique, Beijnen Jos H, Schellens Jan H M and Meijerman Irma. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines. : Toxicology and applied pharmacology. 20060404.